MARKET

ACER

ACER

Acer Therapeutic
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.040
-0.190
-4.49%
After Hours: 4.040 0 0.00% 16:00 01/27 EST
OPEN
4.110
PREV CLOSE
4.230
HIGH
4.230
LOW
3.900
VOLUME
49.37K
TURNOVER
--
52 WEEK HIGH
28.25
52 WEEK LOW
1.871
MARKET CAP
40.78M
P/E (TTM)
-1.2438
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ACER and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ACER News

  • Here's Why We're A Bit Worried About Acer Therapeutics's (NASDAQ:ACER) Cash Burn Situation
  • Simply Wall St..01/05 12:00
  • Acer Therapeutics Says On Dec. 30 Submitted Formal Dispute Resolution Request To FDA Office Of New Drugs Appealing Previously-Announced CRL Regarding Co.'s EDSIVOTM NDA
  • Benzinga.01/02 21:23
  • Hedge Funds Are Betting On Acer Therapeutics Inc. (ACER)
  • Insider Monkey.12/23/2019 20:59
  • The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO
  • Benzinga.12/17/2019 12:56

More

Industry

Biotechnology & Medical Research
-0.88%
Pharmaceuticals & Medical Research
-0.51%

Hot Stocks

Name
Price
%Change

About ACER

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The Company is developing Edsivo for the treatment of vascular Ehlers-Danlos Syndrome (vEDS) in the United States. The Company is developing ACER-001, a pharmacologic treatment option for the treatment of Maple Syrup Urine Disease (MSUD). ACER-001 is an immediate-release formulation of sodium phenylbutyrate (NaPB) developed using a microencapsulation process. The Company is also developing ACER-001 for the treatment of Urea Cycle Disorders (UCD).
More

Webull offers Acer Therapeutics Inc (ACER) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.